Teva Pharmaceutical Industries reported $21.6B in Loan Capital for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Loan Capital Change
Aerie Pharmaceuticals AERI:US $ 222.02M 5.94M
ALKERMES ALKS:US 294.07M 632K
Amarin AMRN:US $ 0M 0M
Amgen AMGN:US $ 28458M 2671M
Antares Pharma ATRS:US $ 3.34M 11.43M
AstraZeneca AZN:LN 24601M 6727M
Biogen BIIB:US $ 7269.2M 2M
Bristol Myers Squibb BMY:US $ 42503M 2002M
Coherus Biosciences CHRS:US $ 287.08M 11.83M
Eli Lilly And LLY:US $ 14736.6M 1463M
Emergent Biosolutions EBS:US $ 825.2M 7.9M
Endo International Ordinary Shares ENDP:US $ 8074.44M 26.54M
Flexion Therapeutics FLXN:US $ 220.02M 14.99M
GlaxoSmithKline GSK:LN 20442M 2605M
Henry Schein HSIC:US $ 706.49M 200.03M
Horizon Pharma HZNP:US $ 2560.44M 2.07M
JAZZ PHA JAZZ:US $ 6495.33M 4642.3M
Lannett LCI:US $ 590.68M 20.02M
Novartis NOVN:VX SF 26491M 908M
Pacira Pharmaceuticals PCRX:US $ 321.71M 4.37M
Patterson Companies PDCO:US $ 487.82M 0.27M
Perrigo Ordinary Shares PRGO:US $ 2925.8M 599.5M
Phibro Animal Health PAHC:US $ 382.71M 25.92M
Revance Therapeutics RVNC:US $ 280M 0.31M
Supernus Pharmaceuticals SUPN:US $ 370.38M 14.15M
Teva Pharmaceutical Industries TEVA:US $ 21602M 686M
Xeris Pharmaceuticals Inc XERS:US $ 87.48M 206K
Zoetis ZTS:US $ 6592M 5M